Skip to main content
. 2018 Mar 22;13(3):e0194366. doi: 10.1371/journal.pone.0194366

Table 1. HBV genetic diversity in three infected individuals characterized by sequencing whole genome PCR products using three different methods.

Sample HBV genotype Direct Sanger sequencing Molecular cloning Direct MinION sequencing
B5584 D1/E Max. sequence length: 3,209-nt Max. sequence length: 3,209-nt Max. sequence length: 3,201 nt
D1/E recombinant sequence Individual D1/E recombinant sequences Individual D1/E recombinant sequences
Single nucleotide ambiguities across whole genome D1 and E parental sequences not detected D1 and E parental sequences not detected
Single nucleotide ambiguities across whole genome*
1,229-nt deletion (pos. 2,471–489)—putative spliced variant
B6505 A2 Max. sequence length: 3,220-nt Not done Max. sequence length: 3,217-nt
Mixed population of wild-type and single nucleotide mutant S sequences Mixed population of wild-type and single nucleotide mutant S sequences
Evaluation of mutation association patterns
1,049-nt deletion (pos. 2,447–282)—putative spliced variant
96-nt deletion (pos. 2,131–2,226)
B6260 D2 Overlapping sequence signals suggesting at least 2 sequences coexisting Individual wild-type sequences (3,179-nt) Max. sequence length: 3,015-nt
Single nucleotide ambiguities across whole genome Individual sequence (3,032-nt) with 123-nt (pos. 2,929–3,051) and 24-nt (pos. 501–524) deletions Individual wild-type sequences
Individual sequences with 123-nt (pos. 2,929–3,051) deletion
Individual sequences with 123-nt (pos. 2,929–3,051) and 24-nt (pos. 501–524) deletions
Single nucleotide ambiguities across whole genome*

* Single nucleotide sequence ambiguities were not investigated further.

Abbreviations: gt, genotype; nt, nucleotide; pos, position.